RFP
DAWN

Root Financial Partners’s Day One Biopharmaceuticals DAWN Stock Holding History

Root Financial Partners’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.18K Buy
335
+329
+5,483% +$4.64K ﹤0.01% 1807
2025
Q4 		$56 Buy
+6
New +$50 ﹤0.01% 2372

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Root Financial Partners's DAWN Position: Q1 2026 in Review

Root Financial Partners increased its Day One Biopharmaceuticals (DAWN) stake by 5,483% in Q1 2026, buying an estimated $4.64K and bringing the position to 335 shares worth $7.18K. The position accounts for ﹤0.01% of the portfolio, ranked #1807.

Root Financial Partners first reported a position in DAWN in Q4 2025 and has held it in 2 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Root Financial Partners held 335 shares of Day One Biopharmaceuticals worth $7.18K as of Q1 2026.
  • Root Financial Partners bought 329 Day One Biopharmaceuticals shares in Q1 2026, an estimated $4.64K.
  • Day One Biopharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #1807 holding.
  • Root Financial Partners first reported a position in Day One Biopharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.